Dr. Tehila Ben Moshe, Our CEO is presenting at the IO360° Summit – Immuno-Oncology 360 Conference.
Tehila will be giving two talks on BND-35, our anti ILT3/LILRB4 antibody and on our INspire platform technology for intracellular delivery of antibodies.
First presentation titled: “INspire – A novel intracellular delivery platform for biologics – expanding the boundaries of biologics.” TRACK A: DISCOVERY, PRECLINICAL & PAYLOAD MODIFICATION (SALON E), Payload Delivery & Modification Lightning Talks
Tuesday, February 27, 2024
04:10 PM – 04:30 PM
Second presentation titled: “BND-35, a superior anti-ILT3 antibody that modulates the suppressive tumor microenvironment.” IO360° BIOTECH SHOWCASE B (NORTHSIDE BALLROOM)
Wednesday, February 28, 2024
10:20 AM – 10:50 AM